P

Inventor

KEMPF DALE J

US87 patents
⚠️ This page may combine multiple inventors who share the name “KEMPF DALE J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBOTT LAB

44 patents
US5635523AJun 3, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB106 citations99
US5541206AJul 30, 1996

Retroviral protease inhibiting compounds

ABBOTT LAB216 citations99
US5354866AOct 11, 1994

Retroviral protease inhibiting compounds

ABBOTT LAB140 citations99
US5142056AAug 25, 1992

Retroviral protease inhibiting compounds

ABBOTT LAB203 citations99
US6037157AMar 14, 2000

Method for improving pharmacokinetics

ABBOTT LAB237 citations97
US5696270ADec 9, 1997

Intermediate for making retroviral protease inhibiting compounds

ABBOTT LAB44 citations97
US5674882AOct 7, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB81 citations97
US6703403B2Mar 9, 2004

Method for improving pharmacokinetics

ABBOTT LAB99 citations96
US6150530ANov 21, 2000

Retroviral protease inhibiting compounds

ABBOTT LAB35 citations96
US5846987ADec 8, 1998

Retroviral protease inhibiting compounds

ABBOTT LAB30 citations96
US5679797AOct 21, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB21 citations96
US5659045AAug 19, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB22 citations96
US5583232ADec 10, 1996

Retroviral protease inhibiting compounds

ABBOTT LAB22 citations96
US5552558ASep 3, 1996

Retroviral protease inhibiting compounds

ABBOTT LAB20 citations96
US5539122AJul 23, 1996

Retroviral protease inhibiting compounds

ABBOTT LAB32 citations96
US5461067AOct 24, 1995

Retroviral protease inhibiting compounds

ABBOTT LAB43 citations96
US5032577AJul 16, 1991

Peptidylaminodiols

ABBOTT LAB68 citations96
US6455571B1Sep 24, 2002

Inhibitors of neuraminidases

ABBOTT LAB60 citations95
US4826815AMay 2, 1989

Renin inhibiting compounds

ABBOTT LAB61 citations95
US7547678B2Jun 16, 2009

Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate

ABBOTT LAB48 citations93
US7320961B2Jan 22, 2008

Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate

ABBOTT LAB50 citations93
US5886036AMar 23, 1999

Retroviral protease inhibiting compounds

ABBOTT LAB23 citations93
US5455351AOct 3, 1995

Retroviral protease inhibiting piperazine compounds

ABBOTT LAB24 citations93
US5256677AOct 26, 1993

Retroviral protease inhibiting compounds

ABBOTT LAB39 citations93
US5151438ASep 29, 1992

Retroviral protease inhibiting compounds

ABBOTT LAB33 citations93
US5905068AMay 18, 1999

Retroviral protease inhibiting compounds

ABBOTT LAB21 citations92
US5545750AAug 13, 1996

Retroviral protease inhibiting compounds

ABBOTT LAB19 citations92
US7763731B2Jul 27, 2010

Anti-viral compounds

ABBOTT LAB37 citations91
US4994477AFeb 19, 1991

Heterocyclic renin inhibitors

ABBOTT LAB31 citations90
US5597928AJan 28, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB17 citations86
US5580984ADec 3, 1996

Retroviral protease inhibiting compounds

ABBOTT LAB16 citations86
US5565418AOct 15, 1996

Retroviral protease inhibiting compounds

ABBOTT LAB16 citations84
US7910595B2Mar 22, 2011

Anti-viral compounds

ABBOTT LAB18 citations83
US6017928AJan 25, 2000

Retroviral protease inhibiting compounds

ABBOTT LAB15 citations82
US5659044AAug 19, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB15 citations82
US5625072AApr 29, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB15 citations82
US5616720AApr 1, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB16 citations82
US5608072AMar 4, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB15 citations82
US5597926AJan 28, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB11 citations82
US5597927AJan 28, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB15 citations82
US5591860AJan 7, 1997

Retroviral protease inhibiting compounds

ABBOTT LAB16 citations82
US5583233ADec 10, 1996

Retroviral protease inhibiting compounds

ABBOTT LAB16 citations82
US4857507AAug 15, 1989

Angiotensinogen analogs

ABBOTT LAB23 citations81
US6284767B1Sep 4, 2001

Retroviral protease inhibiting compounds

ABBOTT LAB14 citations80

KU YIYIN

2 patents

LULY JAY R

1 patent

ABBOTT LABORTORIES

1 patent

ABBOTT LABORAOTRIES

1 patent

MCDANIEL KEITH F

1 patent

Showing the top 50 of 87 patents by PatentIndex Score.